Alimera Sciences Inc (NQ: ALIM )
7.990 USD UNCHANGED Streaming Delayed Price Updated: 4:43 PM EST, Jan 20, 2021 Add to My Watchlist
All news about Alimera Sciences Inc
Alimera Sciences Announces Preliminary Top-line Results for Fourth Quarter and Full-Year 2020
January 19, 2021
54 Biggest Movers From Friday
January 19, 2021
Gainers Yield10 Bioscience, Inc. (NASDAQ: YTEN) shares jumped 76.9% to close at $13.71 on Friday. ObsEva SA (NASDAQ: OBSV) ...
82 Biggest Movers From Friday
January 11, 2021
Gainers LM Funding America, Inc. (NASDAQ: LMFA) shares jumped 177% to close at $2.13on Friday after the company announced ...
12 Health Care Stocks Moving In Thursday's After-Market Session
January 07, 2021
Gainers SCWorx (NASDAQ:WORX) stock moved upwards by 42.4% to $2.25 during Thursday's after-market session. SCWorx's trading ...
Alimera Sciences to Present at the H.C. Wainwright Bioconnect 2021 Virtual Conference
January 05, 2021
52 Stocks Moving In Monday's Mid-Day Session
December 14, 2020
Gainers Arvinas, Inc. (NASDAQ: ARVN) shares jumped 103.4% to $60.87 after the company reported interim clinical data for its ...
Alimera Sciences Announces Launch of ILUVIEN® in the Netherlands
December 09, 2020
ILUVIEN has been launched for both Diabetic Macular Edema and Non-Infectious Posterior Uveitis Indications
Alimera Sciences to Present at the 13th Annual LD Micro Main Event Virtual Conference
December 08, 2020
Alimera Sciences Announces Participation at the 11th Annual Craig-Hallum Alpha Select Conference on Tuesday, November 17, 2020
November 16, 2020
Alimera Sciences Announces Real-World Clinical Data for ILUVIEN® to be Presented at the American Academy of Ophthalmology 2020 Virtual Conference
November 12, 2020
Alimera Sciences Announces Third Quarter 2020 Financial Results
October 28, 2020
The Daily Biotech Pulse: Sanofi-GlaxoSmithKline To Supply 200M Doses To COVID-19 Vaccine Alliance, Gilead Earnings, Biodesix Debuts
October 28, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
The Week Ahead In Biotech: Kala FDA Decision, Merck & Pfizer Earnings, Vaccine Updates And IPOs
October 25, 2020
Biotech stocks posted weekly declines in the week ended Oct. 23, pressured by the broader market decline amid mixed earnings reports and ...
Alimera Sciences to Report Third Quarter 2020 Financial Results on Wednesday, October 28, 2020 and Provide Corporate Update
October 22, 2020
Alimera Sciences Announces Multiple Posters and Papers Highlighting the Durability of ILUVIEN® To Be Presented at the EURETINA 2020 Virtual Congress
September 23, 2020
Alimera Sciences Signs Distribution Agreement With Medis Pharmaceutical to Commercialize Iluvien® in Austria and the Czech Republic
September 15, 2020
Medis will enable immediate access of ILUVIEN to patients in Austria, and will manage reimbursement negotiations for ILUVIEN in the Czech Republic
UPDATE -- Alimera Sciences Announces Participation at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference on September 15, 2020
September 09, 2020
Alimera Sciences Announces Participation at the H.C. Wainwright 22nd Annual Global Virtual Investment Conference on September 15, 2020
September 09, 2020
Alimera Sciences Obtains Reimbursement Approval for ILUVIEN® Use in Non-Infectious Posterior Uveitis in Scotland
September 08, 2020
Continued execution on strategy to grow international sales of ILUVIEN with new territory approvals, expanded reimbursement of posterior uveitis, and further market penetration
Alimera Sciences Announces Enrollment of First Patient in Landmark NEW DAY Clinical Trial to Evaluate ILUVIEN® as Baseline Therapy for Diabetic Macular Edema
September 01, 2020
Alimera Sciences Announces National Reimbursement Granted for ILUVIEN® in the Netherlands
August 26, 2020
ILUVIEN receives pricing and reimbursement approvals for both diabetic macular edema and posterior uveitis indications simultaneously
Alimera Sciences to Present at the LD Micro 500 Virtual Conference on September 2, 2020
August 25, 2020
Alimera Sciences Signs Distribution Agreement With Nordic Prime to Expand International Sales of ILUVIEN® Into Nordic Countries
August 13, 2020
90 Biggest Movers From Yesterday
August 06, 2020
Gainers Biofrontera AG (NASDAQ: BFRA) shares jumped 378.6% to close at $26.80 on Wednesday. MYOS RENS Technology Inc. (NASDAQ: ...
85 Stocks Moving In Wednesday's Mid-Day Session
August 05, 2020
Gainers Biofrontera AG (NASDAQ: BFRA) climbed 151.8% to $14.10. MYOS RENS Technology Inc. (NASDAQ: MYOS) shares climbed 73.4% ...
From Motley Fool
The Daily Biotech Pulse: Bristol-Myers, Bluebird Bio Resubmit Multiple Myeloma Drug BLA, FSD To Close Medicinal Cannabis Business, Hologic's Blowout Quarter
July 30, 2020
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) Abbott Laboratories (NYSE: ABT) ABIOMED, Inc. (NASDAQ: ...
Recap: Alimera Sciences Q2 Earnings
July 29, 2020
Shares of Alimera Sciences (NASDAQ:ALIM) decreased 1.5% after the company reported Q2 results. Quarterly Results Earnings per ...